Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 248

1.

Sugar-Sweetened Beverages and Weight Gain in Children and Adults: A Systematic Review from 2013 to 2015 and a Comparison with Previous Studies.

Luger M, Lafontan M, Bes-Rastrollo M, Winzer E, Yumuk V, Farpour-Lambert N.

Obes Facts. 2017;10(6):674-693. doi: 10.1159/000484566. Epub 2017 Dec 14.

2.

Opportunities for intervention strategies for weight management: global actions on fluid intake patterns.

Lafontan M, Visscher TL, Farpour-Lambert N, Yumuk V.

Obes Facts. 2015;8(1):54-76. doi: 10.1159/000375103. Epub 2015 Jan 29. Review.

3.

Interrelationship between lymphocytes and leptin in fat depots of obese mice revealed by changes in nutritional status.

Lolmède K, Zakaroff-Girard A, Dray C, Renoud ML, Daviaud D, Burcelin R, Lafontan M, Galitzky J, Bouloumié A.

J Physiol Biochem. 2015 Sep;71(3):497-507. doi: 10.1007/s13105-015-0388-x. Epub 2015 Feb 12.

PMID:
25670497
4.

Human white and brite adipogenesis is supported by MSCA1 and is impaired by immune cells.

Estève D, Boulet N, Volat F, Zakaroff-Girard A, Ledoux S, Coupaye M, Decaunes P, Belles C, Gaits-Iacovoni F, Iacovoni JS, Rémaury A, Castel B, Ferrara P, Heymes C, Lafontan M, Bouloumié A, Galitzky J.

Stem Cells. 2015 Apr;33(4):1277-91. doi: 10.1002/stem.1916.

5.

From state to process: defining hydration.

Perrier ET, Armstrong LE, Daudon M, Kavouras S, Lafontan M, Lang F, Péronnet F, Stookey JD, Tack I, Klein A.

Obes Facts. 2014;7 Suppl 2:6-12. doi: 10.1159/000360611. Epub 2014 Apr 4. No abstract available.

6.

H4H - hydration for health.

Lafontan M.

Obes Facts. 2014;7 Suppl 2:1-5. doi: 10.1159/000360666. Epub 2014 Apr 4. No abstract available.

7.

Adipose tissue and adipocyte dysregulation.

Lafontan M.

Diabetes Metab. 2014 Feb;40(1):16-28. doi: 10.1016/j.diabet.2013.08.002. Epub 2013 Oct 16. Review.

PMID:
24139247
8.

[Fat mass expansion, fatty acids and adipokines: metabolic markers and risk factors for cardiovascular pathologies].

Lafontan M.

Ann Pharm Fr. 2013 Jan;71(1):13-26. doi: 10.1016/j.pharma.2012.07.008. Epub 2012 Aug 28. Review. French.

PMID:
23348852
9.

Natriuretic peptides and cGMP signaling control of energy homeostasis.

Moro C, Lafontan M.

Am J Physiol Heart Circ Physiol. 2013 Feb 1;304(3):H358-68. doi: 10.1152/ajpheart.00704.2012. Epub 2012 Nov 30. Review.

10.

Recommendations for healthier hydration: addressing the public health issues of obesity and type 2 diabetes.

Armstrong LE, Barquera S, Duhamel JF, Hardinsyah R, Haslam D, Lafontan M.

Clin Obes. 2012 Oct;2(5-6):115-24. doi: 10.1111/cob.12006.

PMID:
25586246
11.

Physical activity and exercise in the regulation of human adipose tissue physiology.

Thompson D, Karpe F, Lafontan M, Frayn K.

Physiol Rev. 2012 Jan;92(1):157-91. doi: 10.1152/physrev.00012.2011. Review.

12.

Historical perspectives in fat cell biology: the fat cell as a model for the investigation of hormonal and metabolic pathways.

Lafontan M.

Am J Physiol Cell Physiol. 2012 Jan 15;302(2):C327-59. doi: 10.1152/ajpcell.00168.2011. Epub 2011 Sep 7. Review.

13.

Impact of a mechanical massage on gene expression profile and lipid mobilization in female gluteofemoral adipose tissue.

Marques MA, Combes M, Roussel B, Vidal-Dupont L, Thalamas C, Lafontan M, Viguerie N.

Obes Facts. 2011;4(2):121-9. doi: 10.1159/000327347. Epub 2011 Apr 7.

14.

[Kidney, adipose tissue, adipocytes--what's new?].

Lafontan M.

Nephrol Ther. 2011 Apr;7(2):69-79. doi: 10.1016/j.nephro.2010.11.004. Epub 2010 Dec 14. Review. French.

PMID:
21156355
15.

Adipose tissue endothelial cells from obese human subjects: differences among depots in angiogenic, metabolic, and inflammatory gene expression and cellular senescence.

Villaret A, Galitzky J, Decaunes P, Estève D, Marques MA, Sengenès C, Chiotasso P, Tchkonia T, Lafontan M, Kirkland JL, Bouloumié A.

Diabetes. 2010 Nov;59(11):2755-63. doi: 10.2337/db10-0398. Epub 2010 Aug 16.

16.

Lipid mobilization in subcutaneous adipose tissue during exercise in lean and obese humans. Roles of insulin and natriuretic peptides.

Koppo K, Larrouy D, Marques MA, Berlan M, Bajzova M, Polak J, Van de Voorde J, Bülow J, Lafontan M, Crampes F, Langin D, Stich V, de Glisezinski I.

Am J Physiol Endocrinol Metab. 2010 Aug;299(2):E258-65. doi: 10.1152/ajpendo.00767.2009. Epub 2010 May 18.

17.

Neurohumoral and metabolic response to exercise in water.

Wiesner S, Birkenfeld AL, Engeli S, Haufe S, Brechtel L, Wein J, Hermsdorf M, Karnahl B, Berlan M, Lafontan M, Sweep FC, Luft FC, Jordan J.

Horm Metab Res. 2010 May;42(5):334-9. doi: 10.1055/s-0030-1248250. Epub 2010 Feb 22.

PMID:
20178064
18.

Interplay between human adipocytes and T lymphocytes in obesity: CCL20 as an adipochemokine and T lymphocytes as lipogenic modulators.

Duffaut C, Zakaroff-Girard A, Bourlier V, Decaunes P, Maumus M, Chiotasso P, Sengenès C, Lafontan M, Galitzky J, Bouloumié A.

Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1608-14. doi: 10.1161/ATVBAHA.109.192583. Epub 2009 Jul 30.

PMID:
19644053
19.

Lipolysis and lipid mobilization in human adipose tissue.

Lafontan M, Langin D.

Prog Lipid Res. 2009 Sep;48(5):275-97. doi: 10.1016/j.plipres.2009.05.001. Epub 2009 May 21. Review.

PMID:
19464318
20.

Unexpected trafficking of immune cells within the adipose tissue during the onset of obesity.

Duffaut C, Galitzky J, Lafontan M, Bouloumié A.

Biochem Biophys Res Commun. 2009 Jul 10;384(4):482-5. doi: 10.1016/j.bbrc.2009.05.002. Epub 2009 May 5.

PMID:
19422792
21.

Adrenaline but not noradrenaline is a determinant of exercise-induced lipid mobilization in human subcutaneous adipose tissue.

de Glisezinski I, Larrouy D, Bajzova M, Koppo K, Polak J, Berlan M, Bulow J, Langin D, Marques MA, Crampes F, Lafontan M, Stich V.

J Physiol. 2009 Jul 1;587(Pt 13):3393-404. doi: 10.1113/jphysiol.2009.168906. Epub 2009 May 5.

22.

Advances in adipose tissue metabolism.

Lafontan M.

Int J Obes (Lond). 2008 Dec;32 Suppl 7:S39-51. doi: 10.1038/ijo.2008.237. Review.

PMID:
19136990
23.

Atrial natriuretic peptide induces postprandial lipid oxidation in humans.

Birkenfeld AL, Budziarek P, Boschmann M, Moro C, Adams F, Franke G, Berlan M, Marques MA, Sweep FC, Luft FC, Lafontan M, Jordan J.

Diabetes. 2008 Dec;57(12):3199-204. doi: 10.2337/db08-0649. Epub 2008 Oct 3.

24.

Use of the microdialysis technique to assess lipolytic responsiveness of femoral adipose tissue after 12 sessions of mechanical massage technique.

Monteux C, Lafontan M.

J Eur Acad Dermatol Venereol. 2008 Dec;22(12):1465-70. doi: 10.1111/j.1468-3083.2008.02918.x. Epub 2008 Aug 28.

PMID:
18761545
25.

Evidence of in situ proliferation of adult adipose tissue-derived progenitor cells: influence of fat mass microenvironment and growth.

Maumus M, Sengenès C, Decaunes P, Zakaroff-Girard A, Bourlier V, Lafontan M, Galitzky J, Bouloumié A.

J Clin Endocrinol Metab. 2008 Oct;93(10):4098-106. doi: 10.1210/jc.2008-0044. Epub 2008 Aug 5.

PMID:
18682517
26.

Adipose tissue lymphocytes and macrophages in obesity and insulin resistance: makers or markers, and which comes first?

Bouloumié A, Casteilla L, Lafontan M.

Arterioscler Thromb Vasc Biol. 2008 Jul;28(7):1211-3. doi: 10.1161/ATVBAHA.108.168229. No abstract available.

PMID:
18565843
27.

Impact of visceral adipose tissue on liver metabolism and insulin resistance. Part II: Visceral adipose tissue production and liver metabolism.

Girard J, Lafontan M.

Diabetes Metab. 2008 Nov;34(5):439-45. doi: 10.1016/j.diabet.2008.04.002. Epub 2008 Jun 17. Review.

PMID:
18562233
28.

Exercise-induced lipid mobilization in subcutaneous adipose tissue is mainly related to natriuretic peptides in overweight men.

Moro C, Pillard F, de Glisezinski I, Klimcakova E, Crampes F, Thalamas C, Harant I, Marques MA, Lafontan M, Berlan M.

Am J Physiol Endocrinol Metab. 2008 Aug;295(2):E505-13. doi: 10.1152/ajpendo.90227.2008. Epub 2008 Jun 17.

29.

Impact of visceral adipose tissue on liver metabolism. Part I: heterogeneity of adipose tissue and functional properties of visceral adipose tissue.

Lafontan M, Girard J.

Diabetes Metab. 2008 Sep;34(4 Pt 1):317-27. doi: 10.1016/j.diabet.2008.04.001. Epub 2008 Jun 11. Review.

PMID:
18550411
30.

Control of lipolysis by natriuretic peptides and cyclic GMP.

Lafontan M, Moro C, Berlan M, Crampes F, Sengenes C, Galitzky J.

Trends Endocrinol Metab. 2008 May-Jun;19(4):130-7. doi: 10.1016/j.tem.2007.11.006. Epub 2008 Mar 11. Review.

PMID:
18337116
31.

Remodeling phenotype of human subcutaneous adipose tissue macrophages.

Bourlier V, Zakaroff-Girard A, Miranville A, De Barros S, Maumus M, Sengenes C, Galitzky J, Lafontan M, Karpe F, Frayn KN, Bouloumié A.

Circulation. 2008 Feb 12;117(6):806-15. doi: 10.1161/CIRCULATIONAHA.107.724096. Epub 2008 Jan 28.

PMID:
18227385
32.

Phosphodiesterase-5A and neutral endopeptidase activities in human adipocytes do not control atrial natriuretic peptide-mediated lipolysis.

Moro C, Klimcakova E, Lafontan M, Berlan M, Galitzky J.

Br J Pharmacol. 2007 Dec;152(7):1102-10. Epub 2007 Oct 1.

33.

Lipid oxidation according to intensity and exercise duration in overweight men and women.

Pillard F, Moro C, Harant I, Garrigue E, Lafontan M, Berlan M, Crampes F, de Glisezinski I, Rivière D.

Obesity (Silver Spring). 2007 Sep;15(9):2256-62.

34.

Sex differences in lipolysis-regulating mechanisms in overweight subjects: effect of exercise intensity.

Moro C, Pillard F, de Glisezinski I, Crampes F, Thalamas C, Harant I, Marques MA, Lafontan M, Berlan M.

Obesity (Silver Spring). 2007 Sep;15(9):2245-55.

35.

Acute exposure to long-chain fatty acids impairs {alpha}2-adrenergic receptor-mediated antilipolysis in human adipose tissue.

Polak J, Moro C, Bessière D, Hejnova J, Marquès MA, Bajzova M, Lafontan M, Crampes F, Berlan M, Stich V.

J Lipid Res. 2007 Oct;48(10):2236-46. Epub 2007 Jul 11.

36.

Atrial natriuretic peptide contribution to lipid mobilization and utilization during head-down bed rest in humans.

Moro C, Pillard F, de Glisezinski I, Crampes F, Thalamas C, Harant I, Marques MA, Lafontan M, Berlan M.

Am J Physiol Regul Integr Comp Physiol. 2007 Aug;293(2):R612-7. Epub 2007 Jun 6.

37.

Effects of CB1 antagonist on the control of metabolic functions in obese type 2 diabetic patients.

Lafontan M, Piazza PV, Girard J.

Diabetes Metab. 2007 Apr;33(2):85-95. Epub 2007 Apr 5. Review.

PMID:
17418607
38.

Integrated physiology and pathophysiology of CB1-mediated effects of the endocannabinoid system.

Piazza PV, Lafontan M, Girard J.

Diabetes Metab. 2007 Apr;33(2):97-107. Epub 2007 Mar 12. Review.

PMID:
17350871
39.

Atrial natriuretic peptide inhibits the production of adipokines and cytokines linked to inflammation and insulin resistance in human subcutaneous adipose tissue.

Moro C, Klimcakova E, Lolmède K, Berlan M, Lafontan M, Stich V, Bouloumié A, Galitzky J, Arner P, Langin D.

Diabetologia. 2007 May;50(5):1038-47. Epub 2007 Feb 23.

PMID:
17318625
40.
41.

Inhibition of human preadipocyte proteasomal activity by HIV protease inhibitors or specific inhibitor lactacystin leads to a defect in adipogenesis, which involves matrix metalloproteinase-9.

De Barros S, Zakaroff-Girard A, Lafontan M, Galitzky J, Bourlier V.

J Pharmacol Exp Ther. 2007 Jan;320(1):291-9. Epub 2006 Oct 12.

PMID:
17038510
42.

Beta-adrenergic and atrial natriuretic peptide interactions on human cardiovascular and metabolic regulation.

Birkenfeld AL, Boschmann M, Moro C, Adams F, Heusser K, Tank J, Diedrich A, Schroeder C, Franke G, Berlan M, Luft FC, Lafontan M, Jordan J.

J Clin Endocrinol Metab. 2006 Dec;91(12):5069-75. Epub 2006 Sep 19.

43.

Role of adipokines in the control of energy metabolism: focus on adiponectin.

Lafontan M, Viguerie N.

Curr Opin Pharmacol. 2006 Dec;6(6):580-5. Epub 2006 Sep 14. Review.

PMID:
16973420
44.

[Natriuretic peptides: a new lipolytic pathway in human fat cells].

Sengenes C, Moro C, Galitzky J, Berlan M, Lafontan M.

Med Sci (Paris). 2005 Dec;21 Spec No:29-33. Review. French.

PMID:
16598902
45.

Atrial natriuretic peptide stimulates lipid mobilization during repeated bouts of endurance exercise.

Moro C, Polak J, Hejnova J, Klimcakova E, Crampes F, Stich V, Lafontan M, Berlan M.

Am J Physiol Endocrinol Metab. 2006 May;290(5):E864-9. Epub 2005 Nov 15.

46.

Dynamic strength training improves insulin sensitivity and functional balance between adrenergic alpha 2A and beta pathways in subcutaneous adipose tissue of obese subjects.

Polak J, Moro C, Klimcakova E, Hejnova J, Majercik M, Viguerie N, Langin D, Lafontan M, Stich V, Berlan M.

Diabetologia. 2005 Dec;48(12):2631-40. Epub 2005 Nov 5.

PMID:
16273345
47.

An unsuspected metabolic role for atrial natriuretic peptides: the control of lipolysis, lipid mobilization, and systemic nonesterified fatty acids levels in humans.

Lafontan M, Moro C, Sengenes C, Galitzky J, Crampes F, Berlan M.

Arterioscler Thromb Vasc Biol. 2005 Oct;25(10):2032-42. Epub 2005 Aug 25. Review.

PMID:
16123323
48.

Training enhances ANP lipid-mobilizing action in adipose tissue of overweight men.

Moro C, Pillard F, De Glisezinski I, Harant I, Rivière D, Stich V, Lafontan M, Crampes F, Berlan M.

Med Sci Sports Exerc. 2005 Jul;37(7):1126-32.

PMID:
16015128
49.

Norepinephrine induces lipolysis in beta1/beta2/beta3-adrenoceptor knockout mice.

Tavernier G, Jimenez M, Giacobino JP, Hulo N, Lafontan M, Muzzin P, Langin D.

Mol Pharmacol. 2005 Sep;68(3):793-9. Epub 2005 Jun 6.

PMID:
15939797
50.

Fat cells: afferent and efferent messages define new approaches to treat obesity.

Lafontan M.

Annu Rev Pharmacol Toxicol. 2005;45:119-46. Review.

PMID:
15822173

Supplemental Content

Loading ...
Support Center